☆ 4.2 Article

Pharmacological management of co-morbid obstructive sleep apnoea and insomnia

EXPERT OPINION ON PHARMACOTHERAPY (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway

Bruce Corser et al.

Summary: The study explored the use of atomoxetine and oxybutynin in the treatment of obstructive sleep apnea (OSA) but found that they may be poorly tolerated due to their effect on arousal threshold. A combination of atomoxetine with two hypnotics, trazodone and lemborexant, was tested and found to significantly reduce apnea-hypopnea index and hypoxic burden. However, it did not improve total sleep time and worsened self-reported sleep quality.

JOURNAL OF CLINICAL SLEEP MEDICINE (2023)

Add to Collection

Article Clinical Neurology

Effect of altitude and acetazolamide on sleep and nocturnal breathing in healthy lowlanders 40 y of age or older. Data from a randomized trial

Laura C. Graf et al.

Summary: This study assessed the sleep and nocturnal breathing disturbances in healthy lowlanders aged 40 or above at high altitudes. The results showed that preventive treatment with acetazolamide improved oxygenation and nocturnal breathing but had no significant effect on sleep duration and structure.

SLEEP (2023)

Add to Collection

Editorial Material Clinical Neurology

The scent of love is in the air(way): a potential drug target for sleep apnea?

Amal M. Osman et al.

SLEEP (2023)

Add to Collection

Review Clinical Neurology

Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations

Maria P. Mogavero et al.

Summary: After describing orexins and their roles in sleep and medical disorders, the article discusses the clinical evidence on the effects of DORAs and SORAs on insomnia to provide recommendations for further assessment in personalized and precision medicine. Trials with orexin receptor antagonists have shown potential as a valid therapeutic option for insomnia in various medical conditions, but more studies are needed to determine the most suitable options for different patient populations.

NATURE AND SCIENCE OF SLEEP (2023)

Add to Collection

Review Biology

Adherence to CPAP Treatment: Can Mindfulness Play a Role?

Athanasia Pataka et al.

Summary: Obstructive sleep apnea (OSA) is a chronic disease that requires long-term multidisciplinary management. Continuous Positive Airway Pressure (CPAP) is the gold standard of therapy, but poor adherence is a limitation. Mindfulness interventions may increase CPAP adherence and improve sleep quality in OSA patients. Controlled trials are needed, but this review supports the hypothesis that mindfulness can be used as an adjunct method to increase CPAP adherence in OSA patients.

LIFE-BASEL (2023)

Add to Collection

Article Clinical Neurology

The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial

Thomas J. Altree et al.

Summary: This study aimed to investigate the effects of reboxetine alone and in combination with oxybutynin on obstructive sleep apnea (OSA) severity. The findings showed that reboxetine alone significantly reduced the occurrence of OSA, while oxybutynin did not have additional effects. These findings provide important insights for the development of pharmacotherapy for OSA.

JOURNAL OF CLINICAL SLEEP MEDICINE (2023)

Add to Collection

Review Clinical Neurology

The effect of cognitive behavioural therapy for insomnia in people with comorbid insomnia and sleep apnoea: A systematic review and meta-analysis

Alexander Sweetman et al.

Summary: Comorbid insomnia and sleep apnoea (COMISA) is a common and debilitating sleep disorder. Cognitive behavioural therapy for insomnia (CBTi) has shown to be effective in treating COMISA patients, according to a systematic review and meta-analysis of previous studies.

JOURNAL OF SLEEP RESEARCH (2023)

Add to Collection

Article Clinical Neurology

Neurocognitive functioning in comorbid insomnia and sleep apnea patients is better after positive airway pressure therapy, but worse after cognitive behavioral therapy for insomnia: exploratory analysis of cognitive outcomes from the Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea study

Arlener D. Turner et al.

Summary: This study investigated the neurocognitive functioning and treatment effects in individuals with comorbid insomnia and sleep apnea (COMISA). The results showed that the COMISA sample had worse neurocognitive performance at baseline compared to other groups. Treatment combinations involving cognitive behavioral therapy and positive airway pressure were effective in improving symptoms.

SLEEP (2023)

Add to Collection

Article Clinical Neurology

0354 Effect of Lemborexant on Sleep Architecture in Subjects with Comorbid Insomnia and Mild Obstructive Sleep Apnea from a Ph 3 Trial

Clete Kushida et al.

SLEEP (2023)

Add to Collection

Article Multidisciplinary Sciences

Respiratory arousal threshold among patients with isolated sleep apnea and with comorbid insomnia (COMISA)

Marcela Yanagimori et al.

Summary: Insomnia and obstructive sleep apnea (OSA) are common sleep disorders and often coexist. Arousals from sleep may be the common link explaining the frequent comorbidity of both disorders. However, the impact of COMISA on respiratory arousal threshold (AT) is still unclear.

SCIENTIFIC REPORTS (2023)

Add to Collection

Article Critical Care Medicine

Topical Potassium Channel Blockage Improves Pharyngeal Collapsibility A Translational, Placebo-Controlled Trial

Amal M. Osman et al.

Summary: The study investigates the potential of a potassium channel inhibitor, BAY2586116, in improving pharyngeal collapsibility in pigs and humans with obstructive sleep apnea. It demonstrates that acute topical application of BAY2586116 effectively enhances upper-airway collapsibility, highlighting the therapeutic potential of targeting potassium channel mechanisms to treat OSA.

CHEST (2023)

Add to Collection

Review Clinical Neurology

Circadian aspects in the aetiology and pathophysiology of insomnia

Leon C. Lack et al.

Summary: The endogenous circadian pacemaker plays a significant role in insomnia symptoms and may contribute to the development of insomnia disorder. Different insomnia phenotypes are associated with specific circadian timing patterns, and bright light therapy can be used to adjust these rhythms. The relationship between insomnia and circadian rhythm disorders is complex and requires further research and clinical investigation.

JOURNAL OF SLEEP RESEARCH (2023)

Add to Collection

Article Critical Care Medicine

The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial

Paula K. Schweitzer et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Add to Collection

Article Clinical Neurology

Acute and long-term effects of acetazolamide in presumed high loop gain sleep apnea

Yue-Nan Ni et al.

Summary: This study assessed the acute effect and long-term efficacy of acetazolamide (AZT) in high loop gain sleep apnea (HLGSA) patients. The results showed that AZT improved HLGSA in both acute and chronic stages and had positive effects on patients.

SLEEP MEDICINE (2023)

Add to Collection

Review Respiratory System

Pharmacotherapy for obstructive sleep apnea: targeting specific pathophysiological traits

Elisa Perger et al.

Summary: The pathophysiology of obstructive sleep apnea (OSA) is complex and involves various factors. Different pathophysiological traits of OSA have been identified, such as pharyngeal collapsibility, upper airway muscle reactivity, arousal threshold, and regulation of the ventilatory drive. New pharmacological treatments targeting these traits could provide potential options for OSA therapy.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2023)

Add to Collection

Article Respiratory System

One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea A Randomized, Placebo-controlled Trial

Atqiya Aishah et al.

Summary: The combination of noradrenergic and antimuscarinic agents has the potential to improve upper airway function and reduce the severity of obstructive sleep apnea. In a 30-day study, the use of different doses of the combination therapy (ato-oxy) showed promising results in terms of safety and efficacy.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2023)

Add to Collection

Meeting Abstract Clinical Neurology

Effect of Lemborexant on Sleep Onset and Maintenance in Patients with Comorbid Insomnia Disorder and Mild Obstructive Sleep Apnea

Margaret Moline et al.

NEUROLOGY (2023)

Add to Collection

Article Critical Care Medicine

Multinight Prevalence, Variability, and Diagnostic Misclassification of Obstructive Sleep Apnea

Bastien Lechat et al.

Summary: Recent studies suggest that the severity of obstructive sleep apnea (OSA) can vary significantly from night to night, which has important implications for diagnosis and management. This study used a novel under-mattress sleep analyzer to assess OSA prevalence from multinight in-home recordings in a large community sample. The findings reveal a global prevalence of moderate to severe OSA of approximately 20%, and approximately 20% of people diagnosed with a single-night study may be misclassified. These findings emphasize the importance of considering night-to-night variation in OSA diagnosis and management.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Add to Collection

Editorial Material Respiratory System

Current Knowledge and Perspectives for Pharmacological Treatment in OSA

Sebastien Baillieul et al.

ARCHIVOS DE BRONCONEUMOLOGIA (2022)

Add to Collection

Article Respiratory System

Novel avenues to approach non-CPAP therapy and implement comprehensive obstructive sleep apnoea care

Jean-Louis Pepin et al.

Summary: Recent advances in the pathophysiology and translational research of obstructive sleep apnoea (OSA) have opened up new possibilities for treatment and management. By identifying different clinical manifestations and underlying mechanisms, researchers can develop more personalized treatment approaches. Additionally, these studies have shed light on physiological barriers to the use of continuous positive airway pressure (CPAP) treatment in certain patients.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Article Respiratory System

Comorbid insomnia and sleep apnoea is associated with all-cause mortality

Bastien Lechat et al.

Summary: The combined effect of coexisting insomnia and obstructive sleep apnoea on mortality risk is unclear. This study found that comorbid insomnia and sleep apnoea were associated with an increased risk of all-cause mortality.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Article Medicine, General & Internal

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes The STEP 8 Randomized Clinical Trial

Domenica M. Rubino et al.

Summary: In overweight or obese adults without diabetes, once-weekly subcutaneous semaglutide resulted in significantly greater weight loss compared to once-daily subcutaneous liraglutide when added to counseling for diet and physical activity over 68 weeks.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Article Instruments & Instrumentation

Intranasal drug delivery: opportunities and toxicologic challenges during drug development

Lea-Adriana Keller et al.

Summary: In the last decade, there has been a growing interest in intranasal drug delivery in pharmaceutical R&D. This review article highlights the advantages of nasal delivery for local and systemic drug delivery, as well as for CNS indications, compared to conventional systemic approaches. However, formulation limitations and toxicological considerations remain areas that need further optimization in this field.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2022)

Add to Collection

Article Clinical Neurology

A randomized controlled trial of cognitive behavioral therapy for insomnia and PAP for obstructive sleep apnea and comorbid insomnia: effects on nocturnal sleep and daytime performance

Alice Y. Tu et al.

Summary: This study examines the effects of cognitive behavioral therapy for insomnia (CBT-I) and positive airway pressure (PAP) therapy on comorbid insomnia and sleep apnea. The results suggest that CBT-I is more effective in improving sleep and daytime functioning compared to PAP therapy. Concurrent treatment with CBT-I and PAP therapy can lead to faster improvements in sleep and daytime performance.

JOURNAL OF CLINICAL SLEEP MEDICINE (2022)

Add to Collection

Article Clinical Neurology

The association of co-morbid insomnia and sleep apnea with prevalent cardiovascular disease and incident cardiovascular events

Bastien Lechat et al.

Summary: Co-morbid insomnia and sleep apnea are associated with increased risk of cardiovascular disease, but may not predict incidence of cardiovascular events.

JOURNAL OF SLEEP RESEARCH (2022)

Add to Collection

Article Medicine, General & Internal

Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials

Qingyang Shi et al.

Summary: This study summarised the latest evidence on the benefits and harms of weight-lowering drugs. The findings suggest that the combination of phentermine-topiramate and GLP-1 receptor agonists is the most effective, with semaglutide potentially being the most effective GLP-1 receptor agonist.

LANCET (2022)

Add to Collection

Review Clinical Neurology

The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis

Tao Xue et al.

Summary: Multiple large randomized controlled trials have confirmed the efficacy and safety of dual orexin receptor antagonists (DORAs) for primary insomnia. Although there have been few systematic comparisons of different DORAs, it is generally believed that DORAs are superior to placebos in terms of efficacy and safety.

SLEEP MEDICINE REVIEWS (2022)

Add to Collection

Review Geriatrics & Gerontology

Efficacy and safety of Z-substances in the management of insomnia in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing

Vincenz Scharner et al.

Summary: This systematic review investigated the efficacy and safety of Z-drugs in the management of insomnia in older adults. Short-term interventional studies showed that Z-drugs were effective and safe in improving sleep and daytime parameters, but longer-term observational studies indicated an increased risk for falls and fractures. Further studies are needed to evaluate the benefit-risk profile of Z-drugs use in older patients, particularly for long-term use.

BMC GERIATRICS (2022)

Add to Collection

Article Anesthesiology

Obstructive sleep apnea endotypes and their postoperative relevance

Thomas J. Altree et al.

INTERNATIONAL ANESTHESIOLOGY CLINICS (2022)

Add to Collection

Article Critical Care Medicine

Reboxetine Plus Oxybutynin for OSA Treatment A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial

Elisa Perger et al.

Summary: The combination therapy of Reb-Oxy significantly reduces the severity of OSA and improves vigilance. These findings highlight the potential of pharmacologic treatment for OSA.

CHEST (2022)

Add to Collection

Article Critical Care Medicine

A Randomized Controlled Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea

Jan Hedner et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis

Franco De Crescenzo et al.

LANCET (2022)

Add to Collection

Article Clinical Neurology

Comorbid Insomnia and Sleep Apnea Assessment and Management Approaches

Alexander Sweetman et al.

SLEEP MEDICINE CLINICS (2022)

Add to Collection

Article Multidisciplinary Sciences

Trazodone changed the polysomnographic sleep architecture in insomnia disorder: a systematic review and meta-analysis

Yongliang Zheng et al.

Summary: This study aimed to evaluate the efficacy of trazodone in altering polysomnographic sleep architecture in patients with insomnia disorder. The results showed that trazodone significantly increased total sleep time and non-rapid eye movement stage 3 sleep, while significantly reducing latency to onset of persistent sleep, number of awakenings, and waking time after persistent sleep onset. However, trazodone may also lead to daytime drowsiness and decreased appetite.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Clinical Neurology

All-Cause Mortality in People with Co-Occurring Insomnia Symptoms and Sleep Apnea: Analysis of the Wisconsin Sleep Cohort

Bastien Lechat et al.

Summary: Co-morbid insomnia symptoms and sleep apnea are associated with worse sleep, daytime function, mental health, and quality of life. This study found that the symptoms of co-morbid insomnia and sleep apnea are associated with an increased risk of all-cause mortality.

NATURE AND SCIENCE OF SLEEP (2022)

Add to Collection

Article Physiology

A single dose of noradrenergic/serotonergic reuptake inhibitors combined with an antimuscarinic does not improve obstructive sleep apnoea severity

Luke D. J. Thomson et al.

Summary: Previous trials have demonstrated that combining noradrenergic reuptake inhibitors with an antimuscarinic can effectively reduce the apnoea-hypopnoea index (AHI) in patients with obstructive sleep apnoea (OSA). However, individually administering noradrenergic or serotonergic agents has shown no significant effectiveness in alleviating OSA. This study aimed to investigate the impact of combining an antimuscarinic with dual noradrenergic/serotonergic reuptake inhibitors on OSA severity. The results showed that the combination of duloxetine and oxybutynin significantly increased the ratio of hypopnoeas to apnoeas and reduced REM sleep time, but neither drug combination significantly improved overall OSA severity or modified key OSA endotypes.

PHYSIOLOGICAL REPORTS (2022)

Add to Collection

Review Medicine, General & Internal

Efficacy of Semaglutide in Treating Obesity: A Systematic Review of Randomized Controlled Trials (RCTs)

Mahvish Anam et al.

Summary: Obesity is a major health problem worldwide, and GLP-1RA drug semaglutide has shown promising efficacy and safety in treating obesity.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Add to Collection

Article Medicine, General & Internal

Overview of the Role of Pharmacological Management of Obstructive Sleep Apnea

Enrique Arredondo et al.

Summary: Obstructive sleep apnea (OSA) is a disease characterized by the recurrent collapse of the upper airway during sleep. Current treatment options include continuous positive airway pressure (CPAP), lifestyle changes, mandibular advancement devices, and surgery. Pharmacological treatment has been researched as a more convenient alternative. Different types of OSA can be targeted using medications such as antidepressants and CNS stimulants.

MEDICINA-LITHUANIA (2022)

Add to Collection

Editorial Material Critical Care Medicine

Weight Loss Is Integral to Obstructive Sleep Apnea Management Ten-Year Follow-up in Sleep AHEAD

Marie-Pierre St-Onge et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Add to Collection

Article Clinical Neurology

Effects of intranasal steroids on continuous positive airway pressure compliance among patients with obstructive sleep apnea

Charnsiri Segsarnviriya et al.

Summary: The addition of an intranasal steroid can reduce nasal symptoms, especially rhinorrhea and congestion, in patients with obstructive sleep apnea initiating CPAP therapy and increase compliance to CPAP after 90 days of treatment.

SLEEP AND BREATHING (2021)

Add to Collection

Article Critical Care Medicine

Sleep Apnea and Insomnia Emerging Evidence for Effective Clinical Management

Jason C. Ong et al.

Summary: This review highlights the clinical challenges and recent advancements in the management of patients with comorbid insomnia and sleep apnea, emphasizing innovative approaches in evaluation and treatment of COMISA and discussing patient-centered care opportunities in integrating characteristics, preferences, and accessibility to optimize patient care.

CHEST (2021)

Add to Collection

Article Clinical Neurology

Selective serotonin reuptake inhibitor use is associated with worse sleep-related breathing disturbances in individuals with depressive disorders and sleep complaints: a retrospective study

Rebecca Robillard et al.

Summary: This study found that in individuals with depressive disorders, the use of antidepressant medications (especially selective serotonin reuptake inhibitors) may be associated with sleep-related respiratory disturbances and decreased oxygen saturation.

JOURNAL OF CLINICAL SLEEP MEDICINE (2021)

Add to Collection

Review Clinical Neurology

The role of acetazolamide in sleep apnea at sea level: a systematic review and meta-analysis

Yue-Nan Ni et al.

Summary: The drug acetazolamide has shown significant improvement in the apnea-hypopnea index and several sleep metrics in central sleep apnea. However, its effectiveness is not significant in obstructive sleep apnea.

JOURNAL OF CLINICAL SLEEP MEDICINE (2021)

Add to Collection

Article Clinical Neurology

Trazodone improves obstructive sleep apnea after ischemic stroke: a randomized, double-blind, placebo-controlled, crossover pilot study

Chung-Yao Chen et al.

Summary: This study found that trazodone treatment significantly improved sleep quality and severity of OSA in post-stroke patients, especially during rapid eye movement sleep. Patients who responded well to the treatment showed a significant reduction in apnea-hypopnea index after the therapy.

JOURNAL OF NEUROLOGY (2021)

Add to Collection

Review Clinical Neurology

Bi-directional relationships between co-morbid insomnia and sleep apnea (COMISA)

Alexander Sweetman et al.

Summary: Insomnia and obstructive sleep apnea frequently co-occur, with co-morbid insomnia and sleep apnea (COMISA) leading to greater morbidity for patients, complex diagnostic decisions for clinicians, and reduced response to treatment. Understanding the bidirectional relationships between insomnia and OSA is crucial for guiding personalized diagnostic and treatment approaches.

SLEEP MEDICINE REVIEWS (2021)

Add to Collection

Article Physiology

Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity

Atqiya Aishah et al.

Summary: This study investigated the effects of atomoxetine combined with two different antimuscarinics on OSA severity and upper airway physiology. The results showed that the combination of atomoxetine and solifenacin improved respiratory events and oxygenation, while the combination of atomoxetine and biperiden reduced next-day sleepiness.

JOURNAL OF APPLIED PHYSIOLOGY (2021)

Add to Collection

Article Critical Care Medicine

Physiological Traits and Adherence to Sleep Apnea Therapy in Individuals with Coronary Artery Disease

Andrey Zinchuk et al.

Summary: This study found that a low ArTH, as well as very low and high <(V)over dot> comp, are associated with worse long-term CPAP adherence in patients with CAD and OSA. Physiological traits, along with established determinants, may help predict and improve CPAP adherence.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Add to Collection

Letter Respiratory System

BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN)

Thomas Gaisl et al.

EUROPEAN RESPIRATORY JOURNAL (2021)

Add to Collection

Review Clinical Neurology

Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea

Sarah Ronnebaum et al.

Summary: The study compared the efficacy and safety of medications (solriamfetol, modafinil, and armodafinil) used to treat excessive daytime sleepiness associated with obstructive sleep apnea. The results showed various levels of improvement in ESS, MWT20, and CGI-C after 12 weeks of treatment, with similar safety risks among participants.

JOURNAL OF CLINICAL SLEEP MEDICINE (2021)

Add to Collection

Article Neurosciences

The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial

Richard Lim et al.

Summary: The combination of noradrenergic agent reboxetine and anti-muscarinic hyoscine butylbromide has been shown to improve upper airway function during sleep in healthy individuals and reduce obstructive sleep apnoea (OSA) severity by increasing pharyngeal muscle responsiveness, improving respiratory control, and airway collapsibility without changing the respiratory arousal threshold. This highlights the potential for pharmacotherapy to target these mechanisms to treat OSA.

JOURNAL OF PHYSIOLOGY-LONDON (2021)

Add to Collection

Article Respiratory System

Addition of zolpidem to combination therapy with atomoxetine-oxybutynin increases sleep efficiency and the respiratory arousal threshold in obstructive sleep apnoea: A randomized trial

Ludovico Messineo et al.

Summary: The study investigated the combined effect of zolpidem with Ato-Oxy on sleep efficiency and other standard polysomnography parameters. Results showed that the addition of zolpidem improved sleep efficiency and respiratory arousal threshold, but may also impact next-day alertness.

RESPIROLOGY (2021)

Add to Collection

Article Clinical Neurology

The social and economic cost of sleep disorders

Jared Streatfeild et al.

Summary: The study estimated the economic cost of common sleep disorders in Australia for 2019-2020, with a total cost of $35.4 billion, of which financial costs accounted for $10.0 billion and nonfinancial costs accounted for $25.4 billion. The results suggest that the economic costs associated with sleep disorders are substantial, with the financial component equivalent to 0.73% of Australian gross domestic product.

SLEEP (2021)

Add to Collection

Article Clinical Neurology

Prevalence and associations of co-morbid insomnia and sleep apnoea in an Australian population-based sample

Alexander Sweetman et al.

Summary: Insomnia, obstructive sleep apnoea (OSA), and their co-occurrence (COMISA) were investigated for prevalence and associations in Australian adults. Results showed that COMISA was common and associated with increased medical and psychiatric co-morbidity, as well as poor general health.

SLEEP MEDICINE (2021)

Add to Collection

Review Clinical Neurology

Effects of hypnotics on obstructive sleep apnea endotypes and severity: Novel insights into pathophysiology and treatment

Sophie G. Carter et al.

Summary: Impaired upper airway anatomy is the main cause of obstructive sleep apnea, but there are also other significant contributors including ventilatory control instability and low arousal threshold. Recent studies have focused on targeting specific OSA causes with novel treatments to reduce severity and improve efficacy of existing therapies.

SLEEP MEDICINE REVIEWS (2021)

Add to Collection

Article Environmental Sciences

The Association between Use of Benzodiazepine Receptor Agonists and the Risk of Obstructive Sleep Apnea: A Nationwide Population-Based Nested Case-Control Study

Tien-Wei Hsu et al.

Summary: The study found an increased risk of OSA in patients treated with BZRAs, especially for current users and those with higher cumulative doses. A reduced risk of OSA was found in Z-drug users compared with benzodiazepine users.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Add to Collection

Review Environmental Sciences

Comorbid Insomnia and Obstructive Sleep Apnea (COMISA): Current Concepts of Patient Management

Beatrice Ragnoli et al.

Summary: OSA and insomnia are the two most common sleep disorders among the general population, with a high prevalence of insomnia symptoms in OSA patients leading to the identification of the new disorder COMISA. Combined treatment of PAP and CBTi has shown better patient outcomes, and a patient-centered approach considering individual characteristics and treatment preferences is recommended for optimal clinical management of COMISA patients. Further research is needed to fully understand the impact of these therapies on outcomes for OSA patients with comorbidity.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Add to Collection

Article Clinical Neurology

The social and economic cost of sleep disorders

Jared Streatfeild et al.

Summary: The study estimated the economic cost of common sleep disorders in Australia for 2019-2020, totaling $35.4 billion, with obstructive sleep apnea, insomnia, and restless legs syndrome being the main contributors. Financial costs accounted for $10.0 billion, equivalent to 0.73% of Australian GDP, while the nonfinancial cost was $25.4 billion, representing 3.2% of total Australian burden of disease. The study suggests greater expenditure on detection, treatment, and prevention of sleep disorders is warranted.

SLEEP (2021)

Add to Collection

Article Critical Care Medicine

Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment A Randomized Trial

Yves Dauvilliers et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Add to Collection

Article Cell Biology

Both objective and paradoxical insomnia elicit a stress response involving mitokine production

Morena Martucci et al.

AGING-US (2020)

Add to Collection

Article Critical Care Medicine

Randomized Trial on the Effects of High-Dose Zopiclone on OSA Severity, Upper Airway Physiology, and Alertness

Sophie G. Carter et al.

CHEST (2020)

Add to Collection

Article Clinical Neurology

Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double-blind, placebo-controlled, crossover study

Jocelyn Y. Cheng et al.

JOURNAL OF SLEEP RESEARCH (2020)

Add to Collection

Review Critical Care Medicine

Acetazolamide for OSA and Central Sleep Apnea A Comprehensive Systematic Review and Meta-Analysis

Christopher N. Schmickl et al.

CHEST (2020)

Add to Collection

Article Clinical Neurology

Lower socioeconomic status and co-morbid conditions are associated with reduced continuous positive airway pressure adherence among older adult medicare beneficiaries with obstructive sleep apnea

Emerson M. Wickwire et al.

SLEEP (2020)

Add to Collection

Article Neurosciences

Zolpidem increases sleep efficiency and the respiratory arousal threshold without changing sleep apnoea severity and pharyngeal muscle activity

Ludovico Messineo et al.

JOURNAL OF PHYSIOLOGY-LONDON (2020)

Add to Collection

Article Respiratory System

Cognitive behavioural therapy for insomnia reduces sleep apnoea severity: a randomised controlled trial

Alexander Sweetman et al.

ERJ OPEN RESEARCH (2020)

Add to Collection

Article Clinical Neurology

The effects of zolpidem in obstructive sleep apnea - An open-label pilot study

Jayne C. Carberry et al.

JOURNAL OF SLEEP RESEARCH (2019)

Add to Collection

Article Clinical Neurology

Effect of ramelteon on insomnia severity: evaluation of patient characteristics affecting treatment response

Makoto Uchiyama et al.

SLEEP AND BIOLOGICAL RHYTHMS (2019)

Add to Collection

Article Critical Care Medicine

Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis

Adam V. Benjafield et al.

LANCET RESPIRATORY MEDICINE (2019)

Add to Collection

Article Critical Care Medicine

The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity A Randomized, Placebo-controlled, Double-Blind Crossover Trial

Luigi Taranto-Montemurro et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Add to Collection

Article Clinical Neurology

Reboxetine and hyoscine butylbromide improve upper airway function during nonrapid eye movement and suppress rapid eye movement sleep in healthy individuals

Richard Lim et al.

SLEEP (2019)

Add to Collection

Article Pharmacology & Pharmacy

Benzodiazepines Associated With Acute Respiratory Failure in Patients With Obstructive Sleep Apnea

Sheng-Huei Wang et al.

FRONTIERS IN PHARMACOLOGY (2019)

Add to Collection

Review Neurosciences

Co-Morbid Insomnia and Sleep Apnea (COMISA): Prevalence, Consequences, Methodological Considerations, and Recent Randomized Controlled Trials

Alexander Sweetman et al.

BRAIN SCIENCES (2019)

Add to Collection

Review Medicine, General & Internal

Positional therapy for obstructive sleep apnoea

P. R. Srijithesh et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)

Add to Collection

Article Public, Environmental & Occupational Health

Cognitive-Behavioral Therapy for Insomnia: An Effective and Underutilized Treatment for Insomnia

Jeffrey Rossman

AMERICAN JOURNAL OF LIFESTYLE MEDICINE (2019)

Add to Collection

Article Clinical Neurology

Acetazolamide Reduces Blood Pressure and Sleep-Disordered Breathing in Patients With Hypertension and Obstructive Sleep Apnea: A Randomized Controlled Trial

Davoud Eskandari et al.

JOURNAL OF CLINICAL SLEEP MEDICINE (2018)

Add to Collection

Article Clinical Neurology

Prevalence, Associated Clinical Features, and Impact on Continuous Positive Airway Pressure Use of a Low Respiratory Arousal Threshold Among Male United States Veterans With Obstructive Sleep Apnea

Andrey Zinchuk et al.

JOURNAL OF CLINICAL SLEEP MEDICINE (2018)

Add to Collection

Review Clinical Neurology

Phenotypic approaches to obstructive sleep apnoea - New pathways for targeted therapy

Danny J. Eckert

SLEEP MEDICINE REVIEWS (2018)

Add to Collection

Review Neurosciences

Evaluation of intranasal delivery route of drug administration for brain targeting

Franciska Erdo et al.

BRAIN RESEARCH BULLETIN (2018)

Add to Collection

Article Neurosciences

Serotonin Reuptake Inhibitors in Obstructive Sleep Apnea: Associations in People with and without Epilepsy

Jocelyn Y. Cheng

NEUROLOGY RESEARCH INTERNATIONAL (2018)

Add to Collection

Review Clinical Neurology

Obstructive sleep apnea: current perspectives

Amal M. Osman et al.

NATURE AND SCIENCE OF SLEEP (2018)

Add to Collection

Article Respiratory System

Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem

Jayne C. Carberry et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Add to Collection

Article Clinical Neurology

Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline

Michael J. Sateia et al.

JOURNAL OF CLINICAL SLEEP MEDICINE (2017)

Add to Collection

Article Clinical Neurology

European guideline for the diagnosis and treatment of insomnia

Dieter Riemann et al.

JOURNAL OF SLEEP RESEARCH (2017)

Add to Collection

Article Respiratory System

Co-morbid OSA and insomnia increases depression prevalence and severity in men

Carol J. Lang et al.

RESPIROLOGY (2017)

Add to Collection

Article Clinical Neurology

Comparative efficacy of CPAP, MADs, exercise-training, and dietary weight loss for sleep apnea: a network meta-analysis

Imran H. Iftikhar et al.

SLEEP MEDICINE (2017)

Add to Collection

Review Clinical Neurology

Developing a successful treatment for co-morbid insomnia and sleep apnoea

Alexander M. Sweetman et al.

SLEEP MEDICINE REVIEWS (2017)

Add to Collection

Review Clinical Neurology

Prevalence of obstructive sleep apnea in the general population: A systematic review

Chamara V. Senaratna et al.

SLEEP MEDICINE REVIEWS (2017)

Add to Collection

Review Pharmacology & Pharmacy

Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research

Jaden Brandt et al.

DRUGS IN R&D (2017)

Add to Collection

Review Psychiatry

Effects of Antidepressants on Sleep

Adam Wichniak et al.

CURRENT PSYCHIATRY REPORTS (2017)

Add to Collection

Review Respiratory System

Modafinil/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis

Julia L. Chapman et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Add to Collection

Article Clinical Neurology

Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea

Hong Sun et al.

JOURNAL OF CLINICAL SLEEP MEDICINE (2016)

Add to Collection

Article Clinical Neurology

Zopiclone Increases the Arousal Threshold without Impairing Genioglossus Activity in Obstructive Sleep Apnea

Sophie G. Carter et al.

SLEEP (2016)

Add to Collection

Article Clinical Neurology

Zopiclone Increases the Arousal Threshold without Impairing Genioglossus Activity in Obstructive Sleep Apnea

Sophie G. Carter et al.

SLEEP (2016)

Add to Collection

Review Clinical Neurology

Obstructive Sleep Apnea and Psychiatric Disorders: A Systematic Review

Madhulika A. Gupta et al.

JOURNAL OF CLINICAL SLEEP MEDICINE (2015)

Add to Collection

Article Respiratory System

Trazodone Effects on Obstructive Sleep Apnea and Non-REM Arousal Threshold

Erik T. Smales et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)

Add to Collection

Review Critical Care Medicine

International Classification of Sleep Disorders-Third Edition Highlights and Modifications

Michael J. Sateia

CHEST (2014)

Add to Collection

Article Respiratory System

Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study

Davoud Eskandari et al.

EUROPEAN RESPIRATORY JOURNAL (2014)

Add to Collection

Article Clinical Neurology

Trazodone Increases the Respiratory Arousal Threshold in Patients with Obstructive Sleep Apnea and a Low Arousal Threshold

Danny J. Eckert et al.

SLEEP (2014)

Add to Collection

Article Medicine, General & Internal

Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study

Magnus P. Ekstrom et al.

BMJ-BRITISH MEDICAL JOURNAL (2014)

Add to Collection

Article Critical Care Medicine

Defining Phenotypic Causes of Obstructive Sleep Apnea Identification of Novel Therapeutic Targets

Danny J. Eckert et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Add to Collection

Article Neurosciences

Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea

Bradley A. Edwards et al.

JOURNAL OF PHYSIOLOGY-LONDON (2012)

Add to Collection

Article Clinical Neurology

Enhanced Frontoparietal Synchronized Activation During the Wake-Sleep Transition in Patients with Primary Insomnia

Maria Corsi-Cabrera et al.

SLEEP (2012)

Add to Collection

Article Neurosciences

Prevalence and Perceived Health Associated with Insomnia Based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition Criteria: Results from the America Insomnia Survey

Thomas Roth et al.

BIOLOGICAL PSYCHIATRY (2011)

Add to Collection

Editorial Material Clinical Neurology

Hyperarousal and insomnia

Michael H. Bonnet

SLEEP MEDICINE REVIEWS (2010)

Add to Collection

Article Clinical Neurology

Prevalence of undiagnosed obstructive sleep apnea among adult surgical patients in an academic medical center

Kevin J. Finkel et al.

SLEEP MEDICINE (2009)

Add to Collection

Review Clinical Neurology

Neurobiologic Mechanisms in Chronic Insomnia

Michael Perlis et al.

SLEEP MEDICINE CLINICS (2009)

Add to Collection

Article Clinical Neurology

An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia

M Erman et al.

SLEEP MEDICINE (2006)

Add to Collection

Article Respiratory System

Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude

R Fischer et al.

EUROPEAN RESPIRATORY JOURNAL (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.